Centerbridge Partners’s American Renal Associates Holdings, Inc ARA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-17,615,836
| Closed | -$202M | – | 66 |
|
|
2020
Q4 | $202M | Hold |
17,615,836
| – | – | 17.12% | 2 |
|
|
2020
Q3 | $122M | Hold |
17,615,836
| – | – | 13.6% | 2 |
|
|
2020
Q2 | $115M | Hold |
17,615,836
| – | – | 24.54% | 1 |
|
|
2020
Q1 | $116M | Hold |
17,615,836
| – | – | 28.25% | 1 |
|
|
2019
Q4 | $183M | Hold |
17,615,836
| – | – | 29.57% | 1 |
|
|
2019
Q3 | $111M | Hold |
17,615,836
| – | – | 20.23% | 2 |
|
|
2019
Q2 | $131M | Hold |
17,615,836
| – | – | 16.08% | 3 |
|
|
2019
Q1 | $108M | Hold |
17,615,836
| – | – | 14.85% | 3 |
|
|
2018
Q4 | $203M | Hold |
17,615,836
| – | – | 20.66% | 1 |
|
|
2018
Q3 | $381M | Hold |
17,615,836
| – | – | 24.55% | 1 |
|
|
2018
Q2 | $278M | Hold |
17,615,836
| – | – | 19.52% | 2 |
|
|
2018
Q1 | $332M | Hold |
17,615,836
| – | – | 32.67% | 1 |
|
|
2017
Q4 | $307M | Hold |
17,615,836
| – | – | 34.76% | 1 |
|
|
2017
Q3 | $264M | Hold |
17,615,836
| – | – | 30.71% | 2 |
|
|
2017
Q2 | $327M | Hold |
17,615,836
| – | – | 32.42% | 1 |
|
|
2017
Q1 | $297M | Hold |
17,615,836
| – | – | 26.95% | 2 |
|
|
2016
Q4 | $375M | Hold |
17,615,836
| – | – | 28.39% | 2 |
|
|
2016
Q3 | $322M | Hold |
17,615,836
| – | – | 26.33% | 2 |
|
|
2016
Q2 | $510M | Buy |
+17,615,836
| New | +$490M | 26.45% | 2 |
|
Centerbridge Partners's ARA Position: Q1 2021 in Review
Centerbridge Partners sold out of American Renal Associates Holdings, Inc (ARA) in Q1 2021, closing a stake of 17,615,836 shares — an estimated $202M sold.
Centerbridge Partners first reported a position in ARA in Q2 2016 and held it in 19 quarters. The position peaked at $510M in Q2 2016. 0 funds tracked by Wall St. Rank hold ARA as of Q1 2021.
- Centerbridge Partners reported no remaining American Renal Associates Holdings, Inc position as of Q1 2021 after selling out during the quarter.
- Centerbridge Partners sold 17,615,836 American Renal Associates Holdings, Inc shares in Q1 2021, an estimated $202M.
- Centerbridge Partners first reported a position in American Renal Associates Holdings, Inc in Q2 2016 and held it in 19 quarters.
- Centerbridge Partners's American Renal Associates Holdings, Inc position peaked at $510M in Q2 2016.
- 0 funds tracked by Wall St. Rank held American Renal Associates Holdings, Inc as of Q1 2021.
Based on Centerbridge Partners's 13F filing for Q1 2021, filed 17 May 2021.